RxDoctor Payments Data

Paul Fortin, MD

Orthopaedic Surgery · Royal Oak, MINPI 1780688283

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (58.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Paragon 28, Inc. accounts for 85.2% of it on its own, with 12 other manufacturers making up the rest. Among orthopaedic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$537,071in general payments, 2019–2025

Across 327 payments — averaging $1642.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$458K
  • Vilex LLC$21K
  • Smith+Nephew$15K
  • Extremity Medical$15K
  • Stryker$9K
  • Nuvasive Specialized Orthopedics, Inc.$8K
  • plus $12K from 7 others
$38,111in research payments, 2019–2025

Across 12 payments — averaging $3175.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$38K

What the payments were for

  • Royalty or licence$313,10758%
  • Consulting fees$155,96829%
  • Speaking & faculty fees$13,1632%
  • Travel & lodging$43,9168%
  • Food & beverage$6,9021%
  • Education$4,0161%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$537,071 in reported general payments places this provider in the 95th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$217,061
Medicare patients
354
Services billed
2,269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate16$115
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$75
Meloxicam11$44

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Royal Oak

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →